Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DDR2 expression in breast cancer is associated with blood vessel invasion, basal-like tumors, tumor associated macrophages, regulatory T cells, detection mode and prognosis. | Hum Pathol | 2024 | 38914168 | PubTator, text mining | PubMed |
| Click estradiol dimers with novel aromatic bridging units: synthesis and anticancer evaluation. | J Enzyme Inhib Med Chem | 2024 | 38904149 | PubTator, text mining | PubMed |
| Prognosis and diagnosis of prostate cancer based on hypergraph regularization sparse least partial squares regression algorithm. | Aging (Albany NY) | 2024 | 38829766 | PubTator, text mining | PubMed |
Tobacco Smoke Condensate Induces Morphologic Changes in Human Papillomavirus-Positive Cervical Epithelial Cells Consistent with Epithelial to Mesenchymal Transition (EMT) with Activation of Receptor Tyrosine Kinases and Regulation of TGFB. | Int J Mol Sci | 2024 | 38732119 | PubTator, text mining | PubMed |
| Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies. | Pharmaceuticals (Basel) | 2024 | 38675389 | PubTator, text mining | PubMed |
| Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis. | Mol Cancer Ther | 2024 | 38670553 | PubTator, text mining | PubMed |
| Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression. | JCO Precis Oncol | 2024 | 38635931 | PubTator, text mining | PubMed |
| The Senescent Heart-"Age Doth Wither Its Infinite Variety". | Int J Mol Sci | 2024 | 38612393 | PubTator, text mining | PubMed |
| Correction: Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis. | J Cancer Res Clin Oncol | 2024 | 38546886 | PubTator, text mining | PubMed |
| DDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanisms. | FEBS Open Bio | 2024 | 38538106 | PubTator, text mining | PubMed |
| DNA methylation characteristics associated with chemotherapy resistance in epithelial ovarian cancer. | Heliyon | 2024 | 38468944 | PubTator, text mining | PubMed |
| Correction: MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer. | Biomater Sci | 2024 | 38362932 | PubTator, text mining | PubMed |
| Utilizing the scale-invariant feature transform algorithm to align distance matrices facilitates systematic protein structure comparison. | Bioinformatics | 2024 | 38318777 | PubTator, text mining | PubMed |
| RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants. | JTO Clin Res Rep | 2024 | 38304857 | PubTator, text mining | PubMed |
| Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets. | Cell Commun Signal | 2024 | 38279122 | PubTator, text mining | PubMed |
| Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma. | Respir Res | 2024 | 38273401 | PubTator, text mining | PubMed |
| Collagen in the central nervous system: contributions to neurodegeneration and promise as a therapeutic target. | Mol Neurodegener | 2024 | 38273335 | PubTator, text mining | PubMed |
| Activation and Regulation of Pancreatic Stellate Cells in Chronic Pancreatic Fibrosis: A Potential Therapeutic Approach for Chronic Pancreatitis. | Biomedicines | 2024 | 38255213 | PubTator, text mining | PubMed |
| A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. | Cancers (Basel) | 2024 | 38254823 | PubTator, text mining | PubMed |
| Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection. | Cancers (Basel) | 2024 | 38254762 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=7